Eli Lilly's Q4 FY24 guidance adjustment is due to supply chain factors, not demand, creating an attractive buying opportunity with a 'Buy' rating. Despite a modest 0.6% revenue reduction, LLY ...

Zepbound (tirzepatide) is only available on ... found both methods of drug administration easy to manage. Eli Lilly also states that vial forms are cheaper than the auto-injector pre-filled ...

Telehealth company Ro will offer single-dose vials of Eli Lilly's obesity therapy Zepbound ... to offer the lower-cost version of Zepbound (tirzepatide) made available in August.

Eli Lilly is just weeks away from launching ... but has initially been made available in vials only as Lilly waits for EU approval of the KwikPen format later this year. Northern Ireland still ...

An ad airing Super Bowl Sunday features “America’s deadliest epidemic,” obesity, and what can be done about it with the use of “affordable” compounded weight loss drugs.

Dr Craig Koniver, a family physician in Charleston, South Carolina, said he currently has 200 patients using the same method ...

Compounded weight-loss medications, such as those promoted in the Hims & Hers commercial, aren’t approved by the Food and Drug Administration.

Patients who bought stockpiles of alternative GLP-1 drugs online aren't sure what to do with them after learning that the ...

Eli Lilly and Novo Nordisk ... which in the past offered compounded tirzepatide, in December announced it would be offering single-dose vials of Zepbound to patients with obesity.

Compounded semaglutide is legal, but it's not regulated in the same way as medications like Ozempic and Wegovy.